Jennison Associates’s Immunomedics Inc IMMU Stock Holding History

Jennison Associates’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200,000	Closed	-$17M	–	730
2020 Q3	$17M	Hold	200,000	–	–	0.01%	319
2020 Q2	$7.09M	Sell	200,000 -50,000	-20%	-$1.46M	0.01%	407
2020 Q1	$3.37M	Buy	+250,000	New	+$4.21M	﹤0.01%	427

Jennison Associates's IMMU Position: Q4 2020 in Review

Jennison Associates sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 2,127,474 shares — an estimated $181M sold.

Jennison Associates first reported a position in IMMU in Q2 2017 and held it in 14 quarters. The position peaked at $181M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Jennison Associates reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Jennison Associates sold 2,127,474 Immunomedics Inc shares in Q4 2020, an estimated $181M.
Jennison Associates first reported a position in Immunomedics Inc in Q2 2017 and held it in 14 quarters.
Jennison Associates's Immunomedics Inc position peaked at $181M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Jennison Associates's 13F filing for Q4 2020, filed 5 Feb 2021.